ACTA2 and bladder transitional cell carcinoma: Through IHC assay, we verified the reduced ACTA2 expression levels in tumor tissues compared with the adjacent normal mucosa, indicating a decreased myCAFs abundance in BLCA tissue (Figure 7C).